Immunization Economics Webinar: Measuring inequity in vaccination coverage & cost-of-illness: an introduction to the VERSE toolkit

October 6, 2021

Webinar: Measuring inequity in vaccination coverage & cost-of-illness: an introduction to the VERSE toolkit

Part of the fall 2021 inaugural webinar series of the Immunization Economics SIG that focuses on current research relevant to the immunization economics community of practice.

Following a call from the World Health Organization in 2017 for a dashboard to monitor immunization coverage equity in line with the 2030 Agenda for Sustainable Development, the VERSE project lays out a new methodology and user-friendly toolkit for measuring and tracking multidimensional vaccine-related equity in coverage, economic impact, and health outcomes. This work builds upon existing equity methods and toolkits by expanding the outcomes assessed and providing a method for aggregation across multiple dimensions of inequity including socio-economic, gender-based, and regional to create a composite equity metric that is trackable over time and comparable between settings. This presentation will highlight the VERSE project methods and some of the case-study applications that are ongoing in our partner countries.

Organized by: Immunization Economics SIG

 

Register here.

You May Also Like

VPPN Market Intelligence Series: Europe and Central Asia countries tell us how they leverage market intelligence for their vaccine procurement strategy

The Vaccine Procurement Practitioners Network (VPPN) will conclude their series on market intelligence with a third and final webinar that will take place on Thursday, 5 December 2024, from 1pm to 2pm GMT+1, in English, Russian and French. This webinar will focus on how market intelligence can help with understanding vaccine markets to inform a procurement … Read More

2025 Advanced Course of Vaccinology (ADVAC)

ADVAC is a two-week training program which delivers a comprehensive overview of the various aspects of vaccinology. This advanced Course is for scientists and decision-makers involved in vaccine development, in the elaboration of new vaccination strategies or in policy decisions related to the introduction of new vaccines in public health programmes, at national or international … Read More